← Leaderboards
Ruoxiang Wang
Emory University
$472,425
Attributed
$684,782
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $229.5K · FY2005–22$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$684,782 · 2
By mechanism
R21$684,782 · 2
Top collaborators
- Yi Zhang2 shared
Most similar at Emory University
Same institution · by research overlap
- Sunil Singhal$10,554,167
- Wolfram Siede$1,853,450
- Graeme L Conn$11,467,356
- Allan D. Kirk$41,350,860
- Yong Wan$11,312,987
Others in their field
Top investigators on “American”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Ethan Schreier · Associated Universities, Inc.$207,732,557
Research focus
AmericanAndrogen AntagonistsAnti-Cancer TherapeuticAntimalarialsAntineoplastic AgentsApoptosisApoptoticArtemisininsBiologicalBiological AvailabilityBiological ProcessBioluminescence ImagingBloodCancer CellCancer DiagnosisCancer Drug ResistanceCancer EtiologyCancer TherapyCarbocyaninesCarrier ProteinsCastrationCastration Resistant Prostate CancerCause Of DeathAdvanced Prostate Cancer
Grant awards (4)
ROS Targeted Therapy for Lethal Prostate Cancer$229,533
R21 · FY2022 · CA
ROS Targeted Therapy for Lethal Prostate Cancer$195,181
R21 · FY2021 · CA
Functional characterization of PrLZ in prostate cancer$128,488
R21 · FY2006 · CA · contact PI
Functional characterization of PrLZ in prostate cancer$131,580
R21 · FY2005 · CA